Archives of Dermatological Research

, Volume 303, Issue 8, pp 563–572

Asiaticoside suppresses collagen expression and TGF-β/Smad signaling through inducing Smad7 and inhibiting TGF-βRI and TGF-βRII in keloid fibroblasts

  • Bing Tang
  • Bin Zhu
  • Yueying Liang
  • Liangkuan Bi
  • Zhicheng Hu
  • Bin Chen
  • Kai Zhang
  • Jiayuan Zhu
Original Paper

Abstract

Asiaticoside (ATS) isolated from the leaves of Centella asiatica possesses strong wound-healing properties and reduces scar formation. However, the specific effects of asiaticoside on the formation of keloidal scars remain unknown. In the present study, we evaluated the in vitro effects of asiaticoside on the proliferation, collagen expression, and transforming growth factor (TGF)-β/Smad signaling of keloid-derived fibroblasts. Fibroblasts isolated from keloid tissue and normal skin tissues were treated with asiaticoside at different concentrations. Afterwards, they were subjected to RT-PCR and Western blot analyses. The inhibitory effects of asiaticoside on fibroblast viability were assayed using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Asiaticoside decreased fibroblast proliferation in a time- and dose-dependent manner. It also inhibited type I and type III collagen protein and mRNA expressions. In addition, asiaticoside reduced the expression of both TGF-βRI and TGF-βRII at the transcriptional and translational level. Moreover, it increased the expression of Smad7 protein and mRNA. However, asiaticoside did not influence the expression of Smad2, Smad3, Smad4, phosphorylated Smad2, and phosphorylated Smad3. Taken together, these results suggest that asiaticoside could be of potential use in the treatment and/or prevention of hypertrophic scars and keloids.

Keywords

Asiaticoside Transforming growth factor-β Smad Collagen Keloid 

References

  1. 1.
    Chen SJ, Yuan W, Lo S, Trojanowska M, Varga J (2000) Interaction of smad3 with a proximal smad-binding element of the human alpha2(I) procollagen gene promoter required for transcriptional activation by TGF-beta. J Cell Physiol 183:381–392PubMedCrossRefGoogle Scholar
  2. 2.
    Chen SJ, Yuan W, Mori Y, Levenson A, Trojanowska M, Varga J (1999) Stimulation of type I collagen transcription in human skin fibroblasts by TGF-beta: involvement of Smad 3. J Invest Dermatol 112:49–57PubMedCrossRefGoogle Scholar
  3. 3.
    Cheng CL, Guo JS, Luk J, Koo MWL (2004) The healing effects of Centella extract and asiaticoside on acetic acid induced gastric ulcers in rats. Life Sci 74:2237–2249PubMedCrossRefGoogle Scholar
  4. 4.
    Chin GS, Liu W, Peled Z, Lee TY, Steinbrech DS, Hsu M, Longaker MT (2001) Differential expression of transforming growth factor-beta receptors I and II and activation of Smad 3 in keloid fibroblasts. Plast Reconstr Surg 108:423–429PubMedCrossRefGoogle Scholar
  5. 5.
    Derynck R, Zhang YE (2003) Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425:577–584PubMedCrossRefGoogle Scholar
  6. 6.
    Dienus K, Bayat A, Gilmore BF, Seifert O (2010) Increased expression of fibroblast activation protein-alpha in keloid fibroblasts: implications for development of a novel treatment option. Arch Dermatol Res 302(10):725–731PubMedCrossRefGoogle Scholar
  7. 7.
    Dong MS, Jung SH, Kim HJ, Kim JR, Zhao LX, Lee ES, Lee EJ, Yi JB, Lee N, Cho YB, Kwak WJ, Park YI (2004) Structure-related cytotoxicity and anti-hepatofibric effect of asiatic acid derivatives in rat hepatic stellate cell-line, HSC-T6. Arch Pharm Res 27:512–517Google Scholar
  8. 8.
    Dooley S, Hamzavi J, Breitkopf K, Wiercinska E, Said HM, Lorenzen J, Ten Dijke P, Gressner AM (2003) Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats. Gastroenterology 125:178–191PubMedCrossRefGoogle Scholar
  9. 9.
    Goumans MJ, Mummery C (2000) Functional analysis of the TGFbeta receptor/Smad pathway through gene ablation in mice. Int J Dev Biol 44:253–265PubMedGoogle Scholar
  10. 10.
    Gressner AM, Weiskirchen R (2003) The tightrope of therapeutic suppression of active transforming growth factor-beta: high enough to fall deeply? J Hepatol 39:856–859PubMedCrossRefGoogle Scholar
  11. 11.
    Guo JS, Cheng CL, Koo MWL (2004) Inhibitory effects of Centella asiatica water extract and asiaticoside on inducible nitric oxide synthase during gastric ulcer healing in rats. Planta Med 70:1150–1154PubMedCrossRefGoogle Scholar
  12. 12.
    Hayashi H, Abdollah S, Qiu Y, Cai J, Xu YY, Grinnell BW, Richardson MA, Topper JN, Gimbrone MA, Wrana JL et al (1997) The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling. Cell 89:1165–1173PubMedCrossRefGoogle Scholar
  13. 13.
    Hsu YC, Chen MJ, Yu YM, Ko SY, Chang CC (2010) Suppression of TGF-β1/SMAD pathway and extracellular matrix production in primary keloid fibroblasts by curcuminoids: its potential therapeutic use in the chemoprevention of keloid. Arch Dermatol Res 302(10):717–724PubMedCrossRefGoogle Scholar
  14. 14.
    Huang Y-H, Zhang S-H, Zhen R-X, Xu X-D, Zhen Y-S (2004) Asiaticoside inducing apoptosis of tumor cells and enhancing anti-tumor activity of vincristine. Ai Zheng 23:1599–1604PubMedGoogle Scholar
  15. 15.
    Kimura Y, Sumiyoshi M, Samukawa K-I, Satake N, Sakanaka M (2008) Facilitating action of asiaticoside at low doses on burn wound repair and its mechanism. Eur J Pharmacol 584:415–423PubMedCrossRefGoogle Scholar
  16. 16.
    Kolb M, Margetts PJ, Sime PJ, Gauldie J (2001) Proteoglycans decorin and biglycan differentially modulate TGF-beta-mediated fibrotic responses in the lung. Am J Physiol Lung Cell Mol Physiol 280:L1327–L1334PubMedGoogle Scholar
  17. 17.
    Kopp J, Preis E, Said H, Hafemann B, Wickert L, Gressner AM, Pallua N, Dooley S (2005) Abrogation of transforming growth factor-beta signaling by SMAD7 inhibits collagen gel contraction of human dermal fibroblasts. J Biol Chem 280:21570–21576PubMedCrossRefGoogle Scholar
  18. 18.
    Kryger ZB, Sisco M, Roy NK, Lu L, Rosenberg D, Mustoe TA (2007) Temporal expression of the transforming growth factor-Beta pathway in the rabbit ear model of wound healing and scarring. J Am Coll Surg 205:78–88PubMedCrossRefGoogle Scholar
  19. 19.
    Leask A, Abraham DJ (2004) TGF-beta signaling and the fibrotic response. FASEB J 18:816–827PubMedCrossRefGoogle Scholar
  20. 20.
    Lee YS, Jin D-Q, Kwon EJ, Park SH, Lee E-S, Jeong TC, Nam DH, Huh K, Kim J-A (2002) Asiatic acid, a triterpene, induces apoptosis through intracellular Ca2+ release and enhanced expression of p53 in HepG2 human hepatoma cells. Cancer Lett 186:83–91PubMedCrossRefGoogle Scholar
  21. 21.
    Liu W, Wang DR, Cao YL (2004) TGF-beta: a fibrotic factor in wound scarring and a potential target for anti-scarring gene therapy. Curr Gene Ther 4:123–136PubMedCrossRefGoogle Scholar
  22. 22.
    Lu L, Saulis AS, Liu WR, Roy NK, Chao JD, Ledbetter S, Mustoe TA (2005) The temporal effects of anti-TGF-β1, 2, and 3 monoclonal antibody on wound healing and hypertrophic scar formation. J Am Coll Surg 201:391–397PubMedCrossRefGoogle Scholar
  23. 23.
    Luo S, Benathan M, Raffoul W, Panizzon RG, Egloff DV (2001) Abnormal balance between proliferation and apoptotic cell death in fibroblasts derived from keloid lesions. Plast Reconstr Surg 107:87–96PubMedCrossRefGoogle Scholar
  24. 24.
    Maquart FX, Chastang F, Simeon A, Birembaut P, Gillery P, Wegrowski Y (1999) Triterpenes from Centella asiatica stimulate extracellular matrix accumulation in rat experimental wounds. Eur J Dermatol 9:289–296PubMedGoogle Scholar
  25. 25.
    Mook-Jung I, Shin JE, Yun SH, Huh K, Koh JY, Park HK, Jew SS, Jung MW (1999) Protective effects of asiaticoside derivatives against beta-amyloid neurotoxicity. J Neurosci Res 58:417–425PubMedCrossRefGoogle Scholar
  26. 26.
    Mukhopadhyay A, Khoo A, Cheong HH, Chan SY, Aalami O, Lim IJ, Phan TT (2007) Targeting of Sp1 transcription factor: a novel therapeutic approach for keloids, an in vitro analysis. Exp Dermatol 16:1023–1031PubMedCrossRefGoogle Scholar
  27. 27.
    Seifert O, Mrowietz U (2009) Keloid scarring: bench and bedside. Arch Dermatol Res 301(4):259–272PubMedCrossRefGoogle Scholar
  28. 28.
    Shih B, Bayat A (2010) Genetics of keloid scarring. Arch Dermatol Res 302(5):319–339PubMedCrossRefGoogle Scholar
  29. 29.
    Terada Y, Hanada S, Nakao A, Kuwahara M, Sasaki S, Marumo F (2002) Gene transfer of Smad7 using electroporation of adenovirus prevents renal fibrosis in post-obstructed kidney. Kidney Int 61:S94–S98PubMedCrossRefGoogle Scholar
  30. 30.
    Verrecchia F, Mauviel A (2002) Transforming growth factor-beta signaling through the Smad pathway: role in extracellular matrix gene expression and regulation. J Invest Dermatol 118:211–215PubMedCrossRefGoogle Scholar
  31. 31.
    Wolfram D, Tzankov A, Pülzl P, Piza-Katzer H (2009) Hypertrophic scars and keloids—a review of their pathophysiology, risk factors, and therapeutic management. Dermatol Surg 35:171–181PubMedCrossRefGoogle Scholar
  32. 32.
    Yu H, Bock O, Bayat A, Ferguson MWJ, Mrowietz U (2006) Decreased expression of inhibitory SMAD6 and SMAD7 in keloid scarring. J Plast Reconstr Aesthet Surg 59:221–229PubMedCrossRefGoogle Scholar
  33. 33.
    Yun K-J, Kim J-Y, Kim J-B, Lee K-W, Jeong S-Y, Park H-J, Jung H-J, Cho Y-W, Yun K, Lee K-T (2008) Inhibition of LPS-induced NO and PGE2 production by asiatic acid via NF-kappa B inactivation in RAW 264.7 macrophages: possible involvement of the IKK and MAPK pathways. Int Immunopharmacol 8:431–441PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • Bing Tang
    • 1
  • Bin Zhu
    • 1
  • Yueying Liang
    • 1
  • Liangkuan Bi
    • 1
  • Zhicheng Hu
    • 1
  • Bin Chen
    • 1
  • Kai Zhang
    • 1
  • Jiayuan Zhu
    • 1
  1. 1.Department of BurnsThe First Affiliated Hospital of Sun Yat-sen UniversityGuangzhouChina

Personalised recommendations